Cargando…

Clustering based on adherence data

Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiwuwa-Muyingo, Sylvia, Oja, Hannu, Walker, Sarah A, Ilmonen, Pauliina, Levin, Jonathan, Todd, Jim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068077/
https://www.ncbi.nlm.nih.gov/pubmed/21385451
http://dx.doi.org/10.1186/1742-5573-8-3
_version_ 1782201177811714048
author Kiwuwa-Muyingo, Sylvia
Oja, Hannu
Walker, Sarah A
Ilmonen, Pauliina
Levin, Jonathan
Todd, Jim
author_facet Kiwuwa-Muyingo, Sylvia
Oja, Hannu
Walker, Sarah A
Ilmonen, Pauliina
Levin, Jonathan
Todd, Jim
author_sort Kiwuwa-Muyingo, Sylvia
collection PubMed
description Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over a long follow-up or treatment period, and some measurements may be missing due to death or other reasons. A natural question then is how to describe adherence behavior over the whole period in a simple way. In the literature, measurements over a period are usually combined just by using averages like percentages of compliant days or percentages of doses taken. In the paper we adapt an approach where patient adherence measures are seen as a stochastic process. Repeated measures are then analyzed as a Markov chain with finite number of states rather than as independent and identically distributed observations, and the transition probabilities between the states are assumed to fully describe the behavior of a patient. The patients can then be clustered or classified using their estimated transition probabilities. These natural clusters can be used to describe the adherence of the patients, to find predictors for adherence, and to predict the future events. The new approach is illustrated and shown to be useful with a simple analysis of a data set from the DART (Development of AntiRetroviral Therapy in Africa) trial in Uganda and Zimbabwe.
format Text
id pubmed-3068077
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30680772011-03-31 Clustering based on adherence data Kiwuwa-Muyingo, Sylvia Oja, Hannu Walker, Sarah A Ilmonen, Pauliina Levin, Jonathan Todd, Jim Epidemiol Perspect Innov Methodology Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over a long follow-up or treatment period, and some measurements may be missing due to death or other reasons. A natural question then is how to describe adherence behavior over the whole period in a simple way. In the literature, measurements over a period are usually combined just by using averages like percentages of compliant days or percentages of doses taken. In the paper we adapt an approach where patient adherence measures are seen as a stochastic process. Repeated measures are then analyzed as a Markov chain with finite number of states rather than as independent and identically distributed observations, and the transition probabilities between the states are assumed to fully describe the behavior of a patient. The patients can then be clustered or classified using their estimated transition probabilities. These natural clusters can be used to describe the adherence of the patients, to find predictors for adherence, and to predict the future events. The new approach is illustrated and shown to be useful with a simple analysis of a data set from the DART (Development of AntiRetroviral Therapy in Africa) trial in Uganda and Zimbabwe. BioMed Central 2011-03-08 /pmc/articles/PMC3068077/ /pubmed/21385451 http://dx.doi.org/10.1186/1742-5573-8-3 Text en Copyright ©2011 Kiwuwa-Muyingo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Kiwuwa-Muyingo, Sylvia
Oja, Hannu
Walker, Sarah A
Ilmonen, Pauliina
Levin, Jonathan
Todd, Jim
Clustering based on adherence data
title Clustering based on adherence data
title_full Clustering based on adherence data
title_fullStr Clustering based on adherence data
title_full_unstemmed Clustering based on adherence data
title_short Clustering based on adherence data
title_sort clustering based on adherence data
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068077/
https://www.ncbi.nlm.nih.gov/pubmed/21385451
http://dx.doi.org/10.1186/1742-5573-8-3
work_keys_str_mv AT kiwuwamuyingosylvia clusteringbasedonadherencedata
AT ojahannu clusteringbasedonadherencedata
AT walkersaraha clusteringbasedonadherencedata
AT ilmonenpauliina clusteringbasedonadherencedata
AT levinjonathan clusteringbasedonadherencedata
AT toddjim clusteringbasedonadherencedata